FIH ITA Study - Vesalius TMVr System for Symptomatic Degenerative Mitral Regurgitation
NCT: NCT07470788 · RECRUITING
Brief Summary
This first-in-human study evaluates the safety and performance of the Vesalius Transcatheter Mitral Valve Repair (TMVr) System in patients with degenerative mitral regurgitation. The study will enroll patients who are at high or prohibitive risk for conventional surgical repair or replacement of the mitral valve. Participants will receive implantation of the Vesalius TMVr System and will be followed to assess clinical outcomes, device performance, and any adverse events.
Frequently Asked Questions
What is FIH ITA Study - Vesalius TMVr System for Symptomatic Degenerative Mitral Regurgitation?
FIH ITA Study - Vesalius TMVr System for Symptomatic Degenerative Mitral Regurgitation is a clinical trial registered under NCT07470788. Current status: RECRUITING.
What is the status of NCT07470788?
The current status of NCT07470788 (FIH ITA Study - Vesalius TMVr System for Symptomatic Degenerative Mitral Regurgitation) is: RECRUITING.
When did FIH ITA Study - Vesalius TMVr System for Symptomatic Degenerative Mitral Regurgitation start?
FIH ITA Study - Vesalius TMVr System for Symptomatic Degenerative Mitral Regurgitation started on 2026-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.